Processa Pharmaceuticals, Inc. (PCSA): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$11.25M
Year ended 2024-12-31
2012-12-31: -$2.23M2013-12-31: -$2.57M2014-12-31: -$2.70M2015-12-31: -$873.3K2016-12-31: -$2.18M2017-12-31: -$1.68M2023-12-31: -$8.07M2024-12-31: -$11.25M-$11.25M
2012-12-31 Free Cash Flow (USD) 2024-12-31
Period endedFree Cash FlowChange YoYSource filing
2024-12-31-$11.25Mn/m2026-03-18, From 2024-01-01
2023-12-31-$8.07Mn/a2025-03-20, From 2023-01-01
No annual figure between 2017-12-31 and 2023-12-31.
2017-12-31-$1.68Mn/m2019-04-08, From 2017-01-01
2016-12-31-$2.18Mn/m2018-04-16, From 2016-01-01
2015-12-31-$873.3Kn/m2017-09-25, From 2015-01-01
2014-12-31-$2.70Mn/m2017-06-19, From 2014-01-01
2013-12-31-$2.57Mn/m2015-04-14, From 2013-01-01
2012-12-31-$2.23Mn/a2014-03-27, From 2012-01-01